Hepatology

New research links sleep regularity with wellbeing in people with cirrhosis, based on six months of wearable sleep tracking device.

Mas30 liver grafts were associated with lower graft survival in MASLD recipients, a pattern not seen in metALD or ALD.

Cholecystectomy before PSC diagnosis was linked to a more than fivefold higher risk of liver-related death, cancer or liver transplantation.

Adjuvant capecitabine showed no significant survival benefit in a French real-world study of patients with resected biliary tract cancer, despite a trend towards longer RFS.

Viral hepatitis remained a major global health challenge in 2024, despite progress in HBV vaccination and HCV treatment, according to the WHO Global Hepatitis Report 2026.

Learn how hepatitis D treatment with bulevirtide affects immune recovery and why long-term therapy may be needed to prevent relapse.

Semaglutide showed a nominally significant benefit versus placebo in a phase 2 MASH trial, while zalfermin plus semaglutide did not meet the primary endpoint.

An investigational GLP-1 dual agonist, DD01, reduced liver fat in adults with MASLD or MASH in a phase 2 trial.